ArticleBJS open2025
Recurrence and patient reported outcomes after simultaneous bilateral versus unilateral groin hernia repair: prospective nationwide cohort study.
Article in BJS open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundBilateral groin hernias comprise approximately 25% of all groin hernias, with one side often being asymptomatic/minimally symptomatic. With an increase in minimally invasive approaches, simultaneous bilateral groin hernia repair (B-GHR) is frequently performed in routine practice. However, chronic pain and recurrence remain significant postoperative concerns. This study evaluated long-term outcomes after B-GHR versus unilateral groin hernia repairs (U-GHR).
methodsThis nationwide population-based cohort study used prospective data from the Swedish Hernia Register, combined with a patient-reported outcome measure (PROM) questionnaire. All men and women aged ≥ 15 years with groin hernia repair registered between 1 September 2012 and 31 December 2018 were included in the study. Primary outcomes were chronic pain and patient dissatisfaction 1 year after B-GHR versus U-GHR. Secondary outcomes included reoperation for recurrence up until 2020, and risk factors for these long-term outcomes exclusively after B-GHR.
resultsIn all, 65 749 patients provided PROM data for analysis (response rate 69.4%). Chronic pain at 1 year was reported by 16.2% of patients (27) after B-GHR and by 15.4% of patients (9232) after U-GHR. A higher proportion of women undergoing B-GHR reported increased chronic pain than men (23.0 versus 15.4%; P < 0.001). Multivariable regression analyses revealed a higher risk of chronic pain (odds ratio (OR) 1.14; P = 0.002) and patient dissatisfaction (OR 1.30; P < 0.001) after B-GHR than U-GHR. Female sex and age < 50 years were independent risk factors for chronic pain and patient dissatisfaction after B-GHR. No significant difference was observed in reoperation rates for recurrence.
conclusionsB-GHR is associated with an increased risk of chronic pain and patient dissatisfaction compared with U-GHR. Women and younger patients are particularly at risk, suggesting a more cautious approach to simultaneous B-GHR in routine practice, especially in the absence of clear symptoms, and highlighting the importance of watchful waiting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.